Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures

  • Marianna Prokopi
    King's British Heart Foundation Centre, King's College London, London, United Kingdom;
  • Giordano Pula
    King's British Heart Foundation Centre, King's College London, London, United Kingdom;
  • Ursula Mayr
    King's British Heart Foundation Centre, King's College London, London, United Kingdom;
  • Cécile Devue
    Paris-Cardiovascular Research Center, Inserm U970, Hôpital Européen Georges Pompidou, Université Paris-Descartes, Paris, France;
  • Joy Gallagher
    King's College Hospital, National Health Service (NHS) Foundation Trust, Blood Sciences Laboratory Services, London, United Kingdom;
  • Qingzhong Xiao
    King's British Heart Foundation Centre, King's College London, London, United Kingdom;
  • Chantal M. Boulanger
    Paris-Cardiovascular Research Center, Inserm U970, Hôpital Européen Georges Pompidou, Université Paris-Descartes, Paris, France;
  • Nigel Westwood
    Department of Haematological Medicine, King's College London, London, United Kingdom;
  • Carmen Urbich
    Molecular Cardiology, Department of Medicine III, University of Frankfurt, Frankfurt, Germany;
  • Johann Willeit
    Department of Neurology, Medical University Innsbruck, Innsbruck, Austria;
  • Marianne Steiner
    Center for Anatomy and Cell Biology, Medical University Vienna, Vienna, Austria; and
  • Johannes Breuss
    Department of Vascular Biology and Thrombosis Research, Centre for Bio-Molecular Medicine and Pharmacology, Medical University of Vienna, Vienna, Austria
  • Qingbo Xu
    King's British Heart Foundation Centre, King's College London, London, United Kingdom;
  • Stefan Kiechl
    Department of Neurology, Medical University Innsbruck, Innsbruck, Austria;
  • Manuel Mayr
    King's British Heart Foundation Centre, King's College London, London, United Kingdom;

書誌事項

公開日
2009-07-16
DOI
  • 10.1182/blood-2009-02-205930
公開者
American Society of Hematology

この論文をさがす

説明

<jats:title>Abstract</jats:title> <jats:p>The concept of endothelial progenitor cells (EPCs) has attracted considerable interest in cardiovascular research, but despite a decade of research there are still no specific markers for EPCs and results from clinical trials remain controversial. Using liquid chromatography–tandem mass spectrometry, we analyzed the protein composition of microparticles (MPs) originating from the cell surface of EPC cultures. Our data revealed that the conventional methods for isolating mononuclear cells lead to a contamination with platelet proteins. Notably, platelets readily disintegrate into platelet MPs. These platelet MPs are taken up by the mononuclear cell population, which acquires “endothelial” characteristics (CD31, von Willebrand factor [VWF], lectin-binding), and angiogenic properties. In a large population-based study (n = 526), platelets emerged as a positive predictor for the number of colony-forming units and early outgrowth EPCs. Our study provides the first evidence that the cell type consistent with current definitions of an EPC phenotype may arise from an uptake of platelet MPs by mononuclear cells resulting in a gross misinterpretation of their cellular progeny. These findings demonstrate the advantage of using an unbiased proteomic approach to assess cellular phenotypes and advise caution in attributing the benefits in clinical trials using unselected bone marrow mononuclear cells (BMCs) to stem cell-mediated repair.</jats:p>

収録刊行物

  • Blood

    Blood 114 (3), 723-732, 2009-07-16

    American Society of Hematology

被引用文献 (3)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ